Home
>
National Drug Code (NDC)
>
Lofibra
Lofibra - 57844-323-01 - (Fenofibrate)
Drug Information of Lofibra
| Product NDC: | 57844-323 |
| Proprietary Name: | Lofibra |
| Non Proprietary Name: | Fenofibrate |
| Active Ingredient(s): | 134 mg/1 & nbsp; Fenofibrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lofibra
| Product NDC: | 57844-323 |
| Labeler Name: | Teva Select Brands |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075753 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020903 |
Package Information of Lofibra
| Package NDC: | 57844-323-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (57844-323-01) |
NDC Information of Lofibra
| NDC Code | 57844-323-01 |
| Proprietary Name | Lofibra |
| Package Description | 100 CAPSULE in 1 BOTTLE (57844-323-01) |
| Product NDC | 57844-323 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fenofibrate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20020903 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Select Brands |
| Substance Name | FENOFIBRATE |
| Strength Number | 134 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |
